Dark

Check out our Level2View

DMYD
dMY Technology Group, Inc. II
stock NYSE

Inactive

Apr 20, 2021

16.21USD-11.227%(-2.05)1,424,552

Pre-market

0.00USD-100.000%(-18.26)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsTrends

DMYD Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

DMYD Specific Mentions

As of Aug 7, 2026 7:05:48 AM EDT (1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

180 days ago • u/maiboc • r/Baystreetbets • dd_why_diamyd_medical_dmyd_b_could_be_the_biotech • C

Is it DMYD? I can’t search it on Wealthsimple. Is it not available?

180 days ago • u/Ok-Tomato261 • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • C

It’s a different beast than DMYD (Asset Play vs. Blockbuster Revenue), but I love the risk/reward. The only headache for me is accessing the ASX (Australia) from my broker with decent liquidity, but I’ll keep it on the radar. Ideally, they get bought out by a US player looking for that voucher.

180 days ago • u/RAC-City-Mayor • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • C

Very cool.
So I don't know the history here. How did they go from P2 to P3 if it failed? Did they prove it worked on that patient subset and therefore are going for the P3 for that specific subset?
If the drug only really works on that subset, I guess a discount is justified, although if it's 40% of patients instead of 5% of patients it sounds like a good opportunity.
Does Sanofi's drug work on the 40% patient subset being targeted by DMYD?

180 days ago • u/Ok-Tomato261 • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • T

$DMYD: The Asymmetric Trade of 2026. Binary Event in <4 Weeks. 15x Valuation Gap vs. Competitor. 🚀

180 days ago • u/maiboc • r/Baystreetbets • dd_why_diamyd_medical_dmyd_b_could_be_the_biotech • C

Is it DMYD? I can’t search it on Wealthsimple. Is it not available?

180 days ago • u/Ok-Tomato261 • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • C

It’s a different beast than DMYD (Asset Play vs. Blockbuster Revenue), but I love the risk/reward. The only headache for me is accessing the ASX (Australia) from my broker with decent liquidity, but I’ll keep it on the radar. Ideally, they get bought out by a US player looking for that voucher.

180 days ago • u/RAC-City-Mayor • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • C

Very cool.
So I don't know the history here. How did they go from P2 to P3 if it failed? Did they prove it worked on that patient subset and therefore are going for the P3 for that specific subset?
If the drug only really works on that subset, I guess a discount is justified, although if it's 40% of patients instead of 5% of patients it sounds like a good opportunity.
Does Sanofi's drug work on the 40% patient subset being targeted by DMYD?

180 days ago • u/Ok-Tomato261 • r/biotech_stocks • dmyd_the_asymmetric_trade_of_2026_binary_event_in • T

$DMYD: The Asymmetric Trade of 2026. Binary Event in <4 Weeks. 15x Valuation Gap vs. Competitor. 🚀

Share